Inborn errors Congenital defects involve enzyme deficiencies in the carnitine transport or metabolic pathways, such as CPT II deficiency, which affects the function of the carnitine transporter CPT II and leads to impaired fatty acid -oxidation, and CACT deficiency, which affects the function of the carnitine transporter CACT and results in carnitine shuttle dysfunction
The GLP-1 targeted peptide weight loss drugs market refers to the segment of pharmaceuticals that utilize glucagon-like peptide-1 (GLP-1) receptor agonists to promote weight loss and improve metabolic health
In head-to-head trials, patients on tirzepatide lost a greater percentage of their body weight and were more likely to achieve significant milestones like 20% or even 25% total body weight reduction
10.1007/s00401-019-01995-0 Acta Neuropathol
Deuterated Internal Standards for LC-MS: Selection & Custom Synthesis How to Choose the Right Deuterated Labelled Chemical Synthesis Company in Canada How to Choose the Right Deuterium Labelled Compounds Supplier for Your Lab Deuterium-Labelled Compounds Synthesis, Applications & Ordering
